This page is currently under development. An overview of the project will be published shortly. In the meantime, you are welcome to visit https://ghpp.de/en/projects/ for information about further projects within the GHPP. Thank you for your patience. Facts Duration 01.01.2026 - 31.12.2028 Budget…
Context In many countries in Western and South-Eastern Africa, access to safe and effective medicines remains a challenge. A key factor is the limited capacity of national drug quality control laboratories. Insufficient structures, resources or standardised procedures hinder reliable quality testing. As a result, substandard or falsified medicines may reach…
Context Global health crises are on the rise, especially those caused by infectious disease outbreaks, and pose a serious threat to health and well-being. WHO estimates that up to 10 million lives could be saved every year if access to safe and effective medicines and vaccines were improved. As a…
Context The Ebola epidemic and the COVID-19 pandemic have clearly demonstrated that timely access to safe, effective and affordable medicines and vaccines is vital to prevent and fight infectious diseases and protect public health. Many African countries, however, rely on imports of vaccines because national production capacity is insufficient and…